NasdaqCM - Nasdaq Real Time Price USD

Heron Therapeutics, Inc. (HRTX)

Compare
1.0700 +0.0100 (+0.94%)
At close: November 22 at 4:00 PM EST
1.0900 +0.02 (+1.87%)
After hours: November 22 at 5:04 PM EST
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
137,737.0000
127,044.0000
107,672.0000
86,346.0000
88,638.0000
Cost of Revenue
38,305.0000
65,105.0000
54,874.0000
46,021.0000
36,189.0000
Gross Profit
99,432.0000
61,939.0000
52,798.0000
40,325.0000
52,449.0000
Operating Expense
125,353.0000
172,554.0000
227,456.0000
258,153.0000
280,612.0000
Operating Income
-25,921.0000
-110,615.0000
-174,658.0000
-217,828.0000
-228,163.0000
Net Non Operating Interest Income Expense
--
-504.0000
-836.0000
-1,977.0000
1,732.0000
Other Income Expense
-1,542.0000
560.0000
-6,530.0000
-878.0000
-847.0000
Pretax Income
-27,967.0000
-110,559.0000
-182,024.0000
-220,683.0000
-227,278.0000
Net Income Common Stockholders
-27,967.0000
-110,559.0000
-182,024.0000
-220,683.0000
-227,278.0000
Diluted NI Available to Com Stockholders
-27,967.0000
-110,559.0000
-182,024.0000
-220,683.0000
-227,278.0000
Basic EPS
-0.16
-0.80
-1.67
-2.24
-2.50
Diluted EPS
-0.16
-0.80
-1.67
-2.24
-2.50
Basic Average Shares
151,984.5000
138,135.0000
108,996.4070
98,471.0000
90,774.0000
Diluted Average Shares
151,984.5000
138,135.0000
108,996.4070
98,471.0000
90,774.0000
Total Operating Income as Reported
-25,921.0000
-110,615.0000
-174,658.0000
-217,828.0000
-228,163.0000
Total Expenses
163,658.0000
237,659.0000
282,330.0000
304,174.0000
316,801.0000
Net Income from Continuing & Discontinued Operation
-27,967.0000
-110,559.0000
-182,024.0000
-220,683.0000
-227,278.0000
Normalized Income
-27,967.0000
-110,559.0000
-182,024.0000
-220,683.0000
-227,278.0000
Interest Income
--
3,364.0000
1,638.0000
433.0000
3,633.0000
Interest Expense
--
3,868.0000
2,474.0000
2,410.0000
1,901.0000
Net Interest Income
--
-504.0000
-836.0000
-1,977.0000
1,732.0000
EBIT
-21,997.0000
-106,691.0000
-179,550.0000
-218,273.0000
-225,377.0000
EBITDA
-19,371.0000
-103,792.0000
-176,661.0000
-215,252.0000
-222,530.0000
Reconciled Cost of Revenue
38,305.0000
65,105.0000
54,874.0000
46,021.0000
36,189.0000
Reconciled Depreciation
2,626.0000
2,899.0000
2,889.0000
3,021.0000
2,847.0000
Net Income from Continuing Operation Net Minority Interest
-27,967.0000
-110,559.0000
-182,024.0000
-220,683.0000
-227,278.0000
Normalized EBITDA
-19,371.0000
-103,792.0000
-176,661.0000
-215,252.0000
-222,530.0000
12/31/2020 - 8/26/1987

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers